Market research report on the future of Gene Therapies for treatment of a range of disorders
Market research report on the future of Gene Therapies for treatment of a range of disorders
Market research report on the future of Gene Therapies for treatment of a range of disorders
Market research report on the future of outsourcing in the pharmaceutical manufacturing industry
Market research report on the future of outsourcing in the pharmaceutical manufacturing industry
Market research report on the future of outsourcing in the pharmaceutical manufacturing industry
Market research report on the future drugs being developed for the treatment of rare diseases
Market research report on the future drugs being developed for the treatment of rare diseases
Market research report on the future drugs being developed for the treatment of rare diseases
Market research report on the future of non-tyrosine kinase inhibitors for oncological disorders
Market research report on the future of non-tyrosine kinase inhibitors for oncological disorders
Market research report on the future of non-tyrosine kinase inhibitors for oncological disorders
Market research report on the future of outsourced manufacturing of bioipharmaceuticals
Market research report on the future of outsourced manufacturing of bioipharmaceuticals
Market research report on the future of outsourced manufacturing of bioipharmaceuticals
Market research report on the future of novel BBB drugs being developed in the CNS
Market research report on the future of novel BBB drugs being developed in the CNS
Market research report on the future of novel BBB drugs being developed in the CNS
Market research report on the future of sustained released drug delivery systems for ophthalmological disorders
Market research report on the future of sustained released drug delivery systems for ophthalmological disorders
Market research report on the future of sustained released drug delivery systems for ophthalmological disorders
Market research report on the future of 3D Cell Culture technologies / methods for biopharma
Market research report on the future of 3D Cell Culture technologies / methods for biopharma
Market research report on the future of 3D Cell Culture technologies / methods for biopharma
Market research report on the future of Prefilled Syringes for pharmaceuticals / biopharmaceuticals
Market research report on the future of Prefilled Syringes for pharmaceuticals / biopharmaceuticals
Market research report on the future of Prefilled Syringes for pharmaceuticals / biopharmaceuticals
Market research report on various technologies being developed to detect counterfeit drugs
Market research report on various technologies being developed to detect counterfeit drugs
Market research report on various technologies being developed to detect counterfeit drugs
Market research report on the future of Immune Checkpoint Inhibitors in the treatment of oncology drugs
Market research report on the future of Immune Checkpoint Inhibitors in the treatment of oncology drugs
Market research report on the future of Immune Checkpoint Inhibitors in the treatment of oncology drugs
Market research report on the future of Biosimilars
Market research report on the future of Biosimilars
Market research report on the future of Biosimilars
Market research report on the future of protein expression systems market
Market research report on the future of protein expression systems market
Market research report on the future of protein expression systems market
Market research report on the future of NASH drugs market
Market research report on the future of NASH drugs market
Market research report on the future of NASH drugs market
Market research report on the future of T-Cell Immunotherapoes in the biopharmaceuticals industry
Market research report on the future of T-Cell Immunotherapoes in the biopharmaceuticals industry
Market research report on the future of T-Cell Immunotherapoes in the biopharmaceuticals industry
Market research report on the future of microbiome therapeutics
Market research report on the future of microbiome therapeutics
Market research report on the future of microbiome therapeutics
We expect the peptide therapeutics market for metabolic disorders to witness steady growth over the coming decade and be worth over USD 10 b..
We expect the peptide therapeutics market for metabolic disorders to witness steady growth over the coming decade and be worth over USD 10 b..
We expect the peptide therapeutics market for metabolic disorders to witness steady growth over the coming decade and be worth over USD 10 b..
Driven by novel services and advanced technologies, to optimize costs and improve research outcome, the specialty CROs market is likely to g..
Driven by novel services and advanced technologies, to optimize costs and improve research outcome, the specialty CROs market is likely to g..
Driven by novel services and advanced technologies, to optimize costs and improve research outcome, the specialty CROs market is likely to g..
The HPAPI and cytotoxic drugs market offers substantial opportunities for contract manufacturers. We the market to grow at an annualized rat..
The HPAPI and cytotoxic drugs market offers substantial opportunities for contract manufacturers. We the market to grow at an annualized rat..
The HPAPI and cytotoxic drugs market offers substantial opportunities for contract manufacturers. We the market to grow at an annualized rat..
Clinical trial tracker on bispecific antibodies, providing details on various antibodies under development
Clinical trial tracker on bispecific antibodies, providing details on various antibodies under development
Clinical trial tracker on bispecific antibodies, providing details on various antibodies under development
We expect at least eight new anti-CD19 therapies to be made commercially available, till 2030; the market is likely to grow annualized rate ..
We expect at least eight new anti-CD19 therapies to be made commercially available, till 2030; the market is likely to grow annualized rate ..
We expect at least eight new anti-CD19 therapies to be made commercially available, till 2030; the market is likely to grow annualized rate ..
The Fc protein and glycoengineered antibodies market is anticipated to grow at a healthy annualized rate of over 40%, between 2016 and 2026 ..
The Fc protein and glycoengineered antibodies market is anticipated to grow at a healthy annualized rate of over 40%, between 2016 and 2026 ..
The Fc protein and glycoengineered antibodies market is anticipated to grow at a healthy annualized rate of over 40%, between 2016 and 2026 ..
We anticipate the global autoinjectors market to grow at an annualized growth rate of over 8%, over the next ten years
We anticipate the global autoinjectors market to grow at an annualized growth rate of over 8%, over the next ten years
We anticipate the global autoinjectors market to grow at an annualized growth rate of over 8%, over the next ten years
We anticipate the PARP inhibitor drugs market to grow at a healthy annualized rate of 42%, over the period between 2016 and 2026
We anticipate the PARP inhibitor drugs market to grow at a healthy annualized rate of 42%, over the period between 2016 and 2026
We anticipate the PARP inhibitor drugs market to grow at a healthy annualized rate of 42%, over the period between 2016 and 2026
With eight molecules under development, Nektar Therapeutics is expected to play an important role in the evolution of the polymer drug conju..
With eight molecules under development, Nektar Therapeutics is expected to play an important role in the evolution of the polymer drug conju..
With eight molecules under development, Nektar Therapeutics is expected to play an important role in the evolution of the polymer drug conju..
Driven by increasing demand for preventive healthcare, the vaccine contract manufacturing market is anticipated to grow at an annualized rat..
Driven by increasing demand for preventive healthcare, the vaccine contract manufacturing market is anticipated to grow at an annualized rat..
Driven by increasing demand for preventive healthcare, the vaccine contract manufacturing market is anticipated to grow at an annualized rat..
Clinical Trial Tracker, which includes details of various trials underway for T-Cell Immunotherapies
Clinical Trial Tracker, which includes details of various trials underway for T-Cell Immunotherapies
Clinical Trial Tracker, which includes details of various trials underway for T-Cell Immunotherapies
In addition to already marketed products, we expect a number of drug candidates that are in late stages of development, to achieve blockbust..
In addition to already marketed products, we expect a number of drug candidates that are in late stages of development, to achieve blockbust..
In addition to already marketed products, we expect a number of drug candidates that are in late stages of development, to achieve blockbust..
The SGLT2 inhibitor drugs market is anticipated to grow at an annualized growth rate of ~17%, followed by GLP-1 agonists (expected CAGR ~13...
The SGLT2 inhibitor drugs market is anticipated to grow at an annualized growth rate of ~17%, followed by GLP-1 agonists (expected CAGR ~13...
The SGLT2 inhibitor drugs market is anticipated to grow at an annualized growth rate of ~17%, followed by GLP-1 agonists (expected CAGR ~13...
The HDAC inhibitors market is expected to grow at a healthy annualized rate of 32%, over the next decade
The HDAC inhibitors market is expected to grow at a healthy annualized rate of 32%, over the next decade
The HDAC inhibitors market is expected to grow at a healthy annualized rate of 32%, over the next decade
Over the next ten years, the market for novel drugs for the treatment ofglaucoma, is likely to grow at an annualized rate of 83.9%
Over the next ten years, the market for novel drugs for the treatment ofglaucoma, is likely to grow at an annualized rate of 83.9%
Over the next ten years, the market for novel drugs for the treatment ofglaucoma, is likely to grow at an annualized rate of 83.9%
The overall smart wearables market for healthcare applications, is expected to grow at an annualized rate of 13.6%, over the coming years
The overall smart wearables market for healthcare applications, is expected to grow at an annualized rate of 13.6%, over the coming years
The overall smart wearables market for healthcare applications, is expected to grow at an annualized rate of 13.6%, over the coming years
Overall, the dendritic cell- and tumor cell-based cancer vaccines market is expected to grow at a healthy annualized rate of 20.7%, till 203..
Overall, the dendritic cell- and tumor cell-based cancer vaccines market is expected to grow at a healthy annualized rate of 20.7%, till 203..
Overall, the dendritic cell- and tumor cell-based cancer vaccines market is expected to grow at a healthy annualized rate of 20.7%, till 203..
The viral vectors and plasmid DNA manufacturing market is expected to be worth over USD 1 billion, growing at an annualized rate of ~17% ove..
The viral vectors and plasmid DNA manufacturing market is expected to be worth over USD 1 billion, growing at an annualized rate of ~17% ove..
The viral vectors and plasmid DNA manufacturing market is expected to be worth over USD 1 billion, growing at an annualized rate of ~17% ove..
The overall PDE inhibitor drugs market is estimated to be worth over USD 10 billion by 2026
The overall PDE inhibitor drugs market is estimated to be worth over USD 10 billion by 2026
The overall PDE inhibitor drugs market is estimated to be worth over USD 10 billion by 2026
Post the launch of the first wave of products, the market to grow at an annualized rate of 75% till 2030
Post the launch of the first wave of products, the market to grow at an annualized rate of 75% till 2030
Post the launch of the first wave of products, the market to grow at an annualized rate of 75% till 2030
The next generation antibiotics market is expected to grow at an annualized rate of over 30% in the period between 2016 and 2026
The next generation antibiotics market is expected to grow at an annualized rate of over 30% in the period between 2016 and 2026
The next generation antibiotics market is expected to grow at an annualized rate of over 30% in the period between 2016 and 2026
The JAK inhibitors market is expected to grow at an annualized rate of CAGR of 23.5% over the period between 2016 and 2026
The JAK inhibitors market is expected to grow at an annualized rate of CAGR of 23.5% over the period between 2016 and 2026
The JAK inhibitors market is expected to grow at an annualized rate of CAGR of 23.5% over the period between 2016 and 2026
We anticipate the global prefilled syringe market to grow at an annualized rate of 3.9% between 2016 and 2026
We anticipate the global prefilled syringe market to grow at an annualized rate of 3.9% between 2016 and 2026
We anticipate the global prefilled syringe market to grow at an annualized rate of 3.9% between 2016 and 2026
We believe that The T-cell therapy market is likely to be worth USD 25 billion by 2030, representing at an annualized growth rate of over 10..
We believe that The T-cell therapy market is likely to be worth USD 25 billion by 2030, representing at an annualized growth rate of over 10..
We believe that The T-cell therapy market is likely to be worth USD 25 billion by 2030, representing at an annualized growth rate of over 10..
Benlysta® (Human Genome Sciences and GSK) was the first and only drug to be specifially approved for treatment of lupus; there are many othe..
Benlysta® (Human Genome Sciences and GSK) was the first and only drug to be specifially approved for treatment of lupus; there are many othe..
Benlysta® (Human Genome Sciences and GSK) was the first and only drug to be specifially approved for treatment of lupus; there are many othe..
The overall market for large volume wearable injectors is anticipated to grow at an aggressive annualized rate of over 150%
The overall market for large volume wearable injectors is anticipated to grow at an aggressive annualized rate of over 150%
The overall market for large volume wearable injectors is anticipated to grow at an aggressive annualized rate of over 150%
By 2035, the use of deep learning-enabled solutions may result in annual savings of over USD 35 billion within the disease diagnostics segme..
By 2035, the use of deep learning-enabled solutions may result in annual savings of over USD 35 billion within the disease diagnostics segme..
By 2035, the use of deep learning-enabled solutions may result in annual savings of over USD 35 billion within the disease diagnostics segme..
the market for cell therapy manufacturing is anticipated to grow at an annualized rate of ~42%, amounting to a total of around USD 4 billion..
the market for cell therapy manufacturing is anticipated to grow at an annualized rate of ~42%, amounting to a total of around USD 4 billion..
the market for cell therapy manufacturing is anticipated to grow at an annualized rate of ~42%, amounting to a total of around USD 4 billion..
The market for BCMA targeted therapies is expected to grow at an annualized rate of 98% till 2030
The market for BCMA targeted therapies is expected to grow at an annualized rate of 98% till 2030
The market for BCMA targeted therapies is expected to grow at an annualized rate of 98% till 2030
The lyophilization services market for biopharmaceuticals is expected to grow at an annualized growth of 9.5% in the period between 2017 and..
The lyophilization services market for biopharmaceuticals is expected to grow at an annualized growth of 9.5% in the period between 2017 and..
The lyophilization services market for biopharmaceuticals is expected to grow at an annualized growth of 9.5% in the period between 2017 and..
Post the launch of the first wave of products, the cancer metabolism targeting drugs market is anticipated to grow at an annualized rate of ..
Post the launch of the first wave of products, the cancer metabolism targeting drugs market is anticipated to grow at an annualized rate of ..
Post the launch of the first wave of products, the cancer metabolism targeting drugs market is anticipated to grow at an annualized rate of ..
Over the course of the next decade, we expect the current installed capacity of 5.8 GW (excluding PHES) to grow at an annualized rate of 4.9..
Over the course of the next decade, we expect the current installed capacity of 5.8 GW (excluding PHES) to grow at an annualized rate of 4.9..
Over the course of the next decade, we expect the current installed capacity of 5.8 GW (excluding PHES) to grow at an annualized rate of 4.9..
With regard to the geographical activity, in 2017, the US is likely to capture the maximum share (43%) followed by EU5 (34%) and Rest of the..
With regard to the geographical activity, in 2017, the US is likely to capture the maximum share (43%) followed by EU5 (34%) and Rest of the..
With regard to the geographical activity, in 2017, the US is likely to capture the maximum share (43%) followed by EU5 (34%) and Rest of the..
The overall contract manufacturing market in the biopharmaceuticals domain is expected to grow at an annualized rate of 8.7% between 2017 an..
The overall contract manufacturing market in the biopharmaceuticals domain is expected to grow at an annualized rate of 8.7% between 2017 an..
The overall contract manufacturing market in the biopharmaceuticals domain is expected to grow at an annualized rate of 8.7% between 2017 an..
The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
The pharmaceutical contract manufacturing market in China is anticipated to be worth USD 13 Billion by 2030, growing at an annualized rate o..
The novel vaccine delivery devices market is projected to be worth USD 1.5 billion by 2030, growing at a CAGR of 20%, claims Roots Analysis
The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing..
Rising demand for viral vectors coupled to lack of scalability and other concerns related to downstream purification, have led stakeholders ..
The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%...
The high energy / hazardous chemistry API manufacturing services market is anticipated be worth USD 29 billion by 2030, growing at an annual..
Over the coming decade, Asian regions are likely to drive the growth resulting in a share of 29% in 2027
Over the coming decade, Asian regions are likely to drive the growth resulting in a share of 29% in 2027
Over the coming decade, Asian regions are likely to drive the growth resulting in a share of 29% in 2027
Major (>70%) share of antibody discovery services market belongs to North America and Europe, while China market is likely to grow at fast r..
Major (>70%) share of antibody discovery services market belongs to North America and Europe, while China market is likely to grow at fast r..
Major (>70%) share of antibody discovery services market belongs to North America and Europe, while China market is likely to grow at fast r..
The global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030, growing at a CAGR of 34.4%, claims Roots An..
The oncology drug discovery services market is expected to grow at an annualized rate of 6.2%, over the period 2017-2030
The oncology drug discovery services market is expected to grow at an annualized rate of 6.2%, over the period 2017-2030
The oncology drug discovery services market is expected to grow at an annualized rate of 6.2%, over the period 2017-2030
Over the course of the next decade, we expect the installed thin film PV capacity to grow at an annualized rate of about 12.9% (till 2030)
Over the course of the next decade, we expect the installed thin film PV capacity to grow at an annualized rate of about 12.9% (till 2030)
Over the course of the next decade, we expect the installed thin film PV capacity to grow at an annualized rate of about 12.9% (till 2030)
The cell line development services market is expected to grow at an annualized rate of ~10% over the course of the next decade
The cell line development services market is expected to grow at an annualized rate of ~10% over the course of the next decade
The cell line development services market is expected to grow at an annualized rate of ~10% over the course of the next decade
The microbiome therapeutics segment is expected to represent 79% of the total market share in 2030, growing at an annualized growth rate of ..
The microbiome therapeutics segment is expected to represent 79% of the total market share in 2030, growing at an annualized growth rate of ..
The microbiome therapeutics segment is expected to represent 79% of the total market share in 2030, growing at an annualized growth rate of ..
North America (56%) and Europe (26%) are currently the major hubs for antibody related services, and are expected to continue to dominate t..
North America (56%) and Europe (26%) are currently the major hubs for antibody related services, and are expected to continue to dominate t..
North America (56%) and Europe (26%) are currently the major hubs for antibody related services, and are expected to continue to dominate t..
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~34%, during the period 2017-2030
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~34%, during the period 2017-2030
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~34%, during the period 2017-2030
The pharmaceutical / biotechnology modular facilities market is anticipated to grow at an annualized rate of 8.9%, during the period 2017-20..
The pharmaceutical / biotechnology modular facilities market is anticipated to grow at an annualized rate of 8.9%, during the period 2017-20..
The pharmaceutical / biotechnology modular facilities market is anticipated to grow at an annualized rate of 8.9%, during the period 2017-20..
In the foreseen future, mammalian cell lines are likely to remain the major focus of the cell line characterization services market (~82%)
In the foreseen future, mammalian cell lines are likely to remain the major focus of the cell line characterization services market (~82%)
In the foreseen future, mammalian cell lines are likely to remain the major focus of the cell line characterization services market (~82%)
Pharmaceutical, Biotechnology and Medical Devices Market Research Reports highlighting market landscape, market size, market forecasts, segm..
Pharmaceutical, Biotechnology and Medical Devices Market Research Reports highlighting market landscape, market size, market forecasts, segm..
Pharmaceutical, Biotechnology and Medical Devices Market Research Reports highlighting market landscape, market size, market forecasts, segm..
With 20 drugs that are either approved, or in the late stages of development, the ADC therapeutics market is anticipated to grow at a CAGR o..
With 20 drugs that are either approved, or in the late stages of development, the ADC therapeutics market is anticipated to grow at a CAGR o..
With 20 drugs that are either approved, or in the late stages of development, the ADC therapeutics market is anticipated to grow at a CAGR o..
With several anticipated product launches over the coming decade, the non-antibody protein scaffolds market is projected to grow at a CAGR o..
With several anticipated product launches over the coming decade, the non-antibody protein scaffolds market is projected to grow at a CAGR o..
With several anticipated product launches over the coming decade, the non-antibody protein scaffolds market is projected to grow at a CAGR o..
The market for cancer stem cell-based therapies is projected to grow at an annualized rate of ~33%, in the period between 2017 and 2030
The market for cancer stem cell-based therapies is projected to grow at an annualized rate of ~33%, in the period between 2017 and 2030
The market for cancer stem cell-based therapies is projected to grow at an annualized rate of ~33%, in the period between 2017 and 2030
Drug products being developed for indications with large target patient populations are likely to achieve blockbuster status, like Lucentis®..
Drug products being developed for indications with large target patient populations are likely to achieve blockbuster status, like Lucentis®..
Drug products being developed for indications with large target patient populations are likely to achieve blockbuster status, like Lucentis®..
Driven by the evolving nature of cyber threats targeting healthcare players, the cybersecurity market within this domain is expected to grow..
Driven by the evolving nature of cyber threats targeting healthcare players, the cybersecurity market within this domain is expected to grow..
Driven by the evolving nature of cyber threats targeting healthcare players, the cybersecurity market within this domain is expected to grow..
With several approved drugs and late stage clinical candidates, the market is anticipated to grow at an an annualized rate of 14.7% between ..
With several approved drugs and late stage clinical candidates, the market is anticipated to grow at an an annualized rate of 14.7% between ..
With several approved drugs and late stage clinical candidates, the market is anticipated to grow at an an annualized rate of 14.7% between ..
With targeted goals and investments across many regions in the world, the market is anticipated to grow at a steady pace between 2018 and 20..
With targeted goals and investments across many regions in the world, the market is anticipated to grow at a steady pace between 2018 and 20..
With targeted goals and investments across many regions in the world, the market is anticipated to grow at a steady pace between 2018 and 20..
The gene therapy market is anticipated to grow at a steady pace, with an estimated CAGR of 44%, in the period between 2018 and 2030
The gene therapy market is anticipated to grow at a steady pace, with an estimated CAGR of 44%, in the period between 2018 and 2030
The gene therapy market is anticipated to grow at a steady pace, with an estimated CAGR of 44%, in the period between 2018 and 2030
The pharmaceutical contract manufacturing market is expected to grow at an annualized rate of 4.8% till 2028, with an overall capacity of 12..
The pharmaceutical contract manufacturing market is expected to grow at an annualized rate of 4.8% till 2028, with an overall capacity of 12..
The pharmaceutical contract manufacturing market is expected to grow at an annualized rate of 4.8% till 2028, with an overall capacity of 12..
With USD 5.4 billion in financing and substantial partnership activity, the oral proteins and peptides market is projected to be worth USD 1..
With USD 5.4 billion in financing and substantial partnership activity, the oral proteins and peptides market is projected to be worth USD 1..
With USD 5.4 billion in financing and substantial partnership activity, the oral proteins and peptides market is projected to be worth USD 1..
Driven primarily by CAR-T cell-based products, the T-cell immunotherapy market is projected to grow at an annualized rate of over 80%, from ..
Driven primarily by CAR-T cell-based products, the T-cell immunotherapy market is projected to grow at an annualized rate of over 80%, from ..
Driven primarily by CAR-T cell-based products, the T-cell immunotherapy market is projected to grow at an annualized rate of over 80%, from ..
The vector manufacturing market is likely to be worth close to USD 1.7 billion in 2030, with 75% of the demand for such services coming from..
The vector manufacturing market is likely to be worth close to USD 1.7 billion in 2030, with 75% of the demand for such services coming from..
The vector manufacturing market is likely to be worth close to USD 1.7 billion in 2030, with 75% of the demand for such services coming from..
The pharmaceutical spray drying services market is expected to grow at an annualized rate of ~20%, in the period between 2018 and 2028
The pharmaceutical spray drying services market is expected to grow at an annualized rate of ~20%, in the period between 2018 and 2028
The pharmaceutical spray drying services market is expected to grow at an annualized rate of ~20%, in the period between 2018 and 2028
Driven by a growing unmet need and variety of application areas, the next generation batteries market is expected to grow at a CAGR of 50.4%..
Driven by a growing unmet need and variety of application areas, the next generation batteries market is expected to grow at a CAGR of 50.4%..
Driven by a growing unmet need and variety of application areas, the next generation batteries market is expected to grow at a CAGR of 50.4%..
The novel cancer drugs market, targeting previously undruggable biomolecules, is expected to be worth around USD 11-12 billion over the comi..
The novel cancer drugs market, targeting previously undruggable biomolecules, is expected to be worth around USD 11-12 billion over the comi..
The novel cancer drugs market, targeting previously undruggable biomolecules, is expected to be worth around USD 11-12 billion over the comi..
As more drug-device combination products get approved for a diverse range of disease indications, we expect the autoinjectors market to grow..
As more drug-device combination products get approved for a diverse range of disease indications, we expect the autoinjectors market to grow..
As more drug-device combination products get approved for a diverse range of disease indications, we expect the autoinjectors market to grow..
Evolutionary innovation in Parkinson’s disease therapeutics has led to capital investments worth over USD 2 billion in this field, between 2..
Evolutionary innovation in Parkinson’s disease therapeutics has led to capital investments worth over USD 2 billion in this field, between 2..
Evolutionary innovation in Parkinson’s disease therapeutics has led to capital investments worth over USD 2 billion in this field, between 2..
The subcutaneous biologic drugs market, currently estimated to be worth more than USD 80 billion, is expected to grow at an annualized rate ..
The subcutaneous biologic drugs market, currently estimated to be worth more than USD 80 billion, is expected to grow at an annualized rate ..
The subcutaneous biologic drugs market, currently estimated to be worth more than USD 80 billion, is expected to grow at an annualized rate ..
CADD can save as much as 30% of R&D costs, enabling researchers to expedite the clinicnal development process; the market is poised to grow ..
CADD can save as much as 30% of R&D costs, enabling researchers to expedite the clinicnal development process; the market is poised to grow ..
CADD can save as much as 30% of R&D costs, enabling researchers to expedite the clinicnal development process; the market is poised to grow ..
Driven by the rapidly evolving pipeline of ATMPS, the cell therapy manufacturing market is expected to be worth over USD 8 billion by 2030
Driven by the rapidly evolving pipeline of ATMPS, the cell therapy manufacturing market is expected to be worth over USD 8 billion by 2030
Driven by the rapidly evolving pipeline of ATMPS, the cell therapy manufacturing market is expected to be worth over USD 8 billion by 2030
The CAR-T cell therapies market is projected to be worth USD 15 Billion by 2030, with China leading in terms of innovation and ongoing R&D i..
The CAR-T cell therapies market is projected to be worth USD 15 Billion by 2030, with China leading in terms of innovation and ongoing R&D i..
The CAR-T cell therapies market is projected to be worth USD 15 Billion by 2030, with China leading in terms of innovation and ongoing R&D i..
With 8 approved molecules and over 140 clinical/preclinical candidates, the non-opioid pain therapeutics market is likely to grow at an annu..
With 8 approved molecules and over 140 clinical/preclinical candidates, the non-opioid pain therapeutics market is likely to grow at an annu..
